Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Drospirenone vs Desogestrel vs Levonorgestrel POPs Contraceptive Efficacy and Safety
NCT06689150Completed
- Sponsor
- Al-Azhar University
- Start
- Aug 2023
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of drospirenone in pregnancy (3 arms), sponsored by Al-Azhar University. Primary endpoint: Irregular Vaginal Bleeding at 9 months. Started Aug 2023; status: completed.
02
Drugs
drospirenone
03
Conditions
pregnancy
Beyond the preview
Go deeper on NCT06689150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06689150.